Descrizione

The global life science tools and reagents market is set to increase by US$ 48.4 miliardi da 2022 A 2028, che rappresenta un tasso di crescita annuale composto (CAGR) Di 7.2% durante il periodo di previsione.

Il rapporto fornisce dati aggiornati sulle dimensioni del mercato per il periodo 2018-2021 e previsione a 2028 covering key market aspects like sales value for life science tools and reagents. The global life science tools and reagents market is segmented on the basis of product type, applicazione, e regione. In base alla tipologia di prodotto, the global life science tools and reagents market has been segmented into life science tools, life science COVID-19 diagnostics products. Per applicazione, the global life science tools and reagents market has been segmented into animal models, bioinformatics, cell biology, epigenetics, genomics, imaging and microscopy, proteomics, stem cells, altri. Tra questi, the genomics segment was accounted for the highest revenue generator in 2021. In termini di geografia, the global life science tools and reagents market has been segmented into Asia Pacific, Europa, Nord America, Rest of the World (RoW).

The global life science tools and reagents market is highly competitive. The key players in the life science tools and reagents market include Abcam plc, Abnova Corp., Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corp., Bruker Corp., Carl Zeiss Inc., Charles River Laboratories Inc., Danaher Corp., GE Healthcare, GenOway S.A., Hitachi High-Tech Group, Illumina Inc., JEOL Ltd., Labcorp Drug Development, Luminex Corporation, Merck KGaA (includes Sigma Aldrich), Novozymes Inc., Olympus Inc., Perkin Elmer Inc., Perkin Elmer Inc., Plus Therapeutics Inc., Qiagen N.V., Roche Holding AG, Shimadzu Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Waters Corporation.

Il rapporto è una risorsa inestimabile per le aziende e le organizzazioni attive in questo settore. It provides a cohesive picture of the life science tools and reagents market to help drive informed decision making for industry executives, decisori politici, accademico, e analisti.

Ambito del rapporto

Tipologia di prodotto: life science tools, life science COVID-19 diagnostics products
Applicazione: animal models, bioinformatics, cell biology, epigenetics, genomics, imaging and microscopy, proteomics, stem cells, altri
Regione: Asia Pacifico, Europa, Nord America, Rest of the World (RoW)
Anni considerati: la presente relazione copre il periodo 2018 A 2028

Principali vantaggi per gli stakeholder

– Get a comprehensive picture of the global life science tools and reagents market
– Individuare i settori in crescita e le tendenze per gli investimenti

Sommario

Parte 1. introduzione
– Ambito dello studio
– Periodo di studio
– Ambito geografico
– Metodologia di ricerca
Parte 2. Life science tools and reagents market overview
Parte 3. Ripartizione del mercato per tipologia di prodotto
– Life science tools
– Life science COVID-19 diagnostics products
Parte 4. Market breakdown by application
– Animal models
– Bioinformatics
– Cell biology
– Epigenetics
– Genomics
– Imaging and microscopy
– Proteomics
– Stem cells
– Altri
Parte 5. Market breakdown by region
– Asia Pacifico
– Europa
– Nord America
– Rest of the World (RoW)
Parte 6. Aziende chiave
– Abcam plc
– Abnova Corp.
– Agilent Technologies Inc.
– Becton, Dickinson and Company
– Bio-Rad Laboratories, Inc.
– Bio-Techne Corp.
– Bruker Corp.
– Carl Zeiss Inc.
– Charles River Laboratories Inc.
– Danaher Corp.
– GE Healthcare
– GenOway S.A.
– Hitachi High-Tech Group
– Illumina, Inc.
– JEOL Ltd.
– Labcorp Drug Development
– Luminex Corporation
– Merck KGaA (includes Sigma Aldrich)
– Novozymes Inc.
– Olympus Inc.
– Perkin Elmer Inc.
– Perkin Elmer Inc.
– Plus Therapeutics Inc.
– Qiagen N.V.
– Roche Holding AG
– Shimadzu Corporation
– Siemens Healthineers AG
– Thermo Fisher Scientific Inc.
– Waters Corporation
Informazioni su StrategyHelix
Disclaimer